The Human Genome Project solves mystery diseases

By Admin
Share
Written by Alyssa Clark Neurological problems, mystery adult illnesses, mental slowness or unexplainable muscle weakness— these are all problems...

Written by Alyssa Clark

Neurological problems, mystery adult illnesses, mental slowness or unexplainable muscle weakness— these are all problems plaguing today’s people, with no cause or solution in sight. Adults and children alike experience strange symptoms whether it be neurologically or physically, but now scientists are suggesting a possible crack in the code when determining the cause of these mystery illnesses. The solution: an analysis of a person’s genetic makeup.

"Many of these are children or adults that have had a mystery illness for many years. Their families don't know what it is and they're sort of desperate for an answer," and it's not possible to find a treatment until you find the cause, he said.

This study is breaking ground as the first of its kind, in a large scale effort to move gene sequencing out of the laboratory and into the everyday practice of medical care— hopes are set pretty high that this technology will pay off.

"This is a direct benefit of the Human Genome Project," the big effort to decode our DNA, said Dr. Christine M. Eng of Baylor College of Medicine in Houston. "We're now able to directly benefit patients through more accurate diagnosis."

The study was published last Wednesday online, in the New England Journal of Medicine with Dr. Eng leading the study. The most recent results show a survey of the 250 patients who were referred to Dr. Eng for her work in a newer type of sequencing (DNA segments which hold the recipes for all the body needs). This type of analysis only accounts for 1 percent of the entire human genome. A total of 1,700 patients have undergone the study so far at Baylor, as they have branched out in testing more patients outside of the study. Eng reported that genome flaws were found in 1 out of 4 people tested.

As more genes are linked to diseases, the diagnoses rate will go us. It already is much higher than it has been in the past, due to the complexity and thorough workings of the genome test.

"For some of these conditions there could be treatments that are lifesaving," said Rebecca Nagy, a scientist at Ohio State University and president of the National Society of Genetic Counselors.

In the initial study of analyzing genes in order to diagnose mystery illnesses of the 2250 patients, 62 of them were found to have genetic flaws. In 33 of those specific cases, only one faulty copy of a gene was responsible. In all 16 other cases, both copies of the gene were bad. Four patients had problems in two different genes, and nine patients had faulty genes on the X chromosome, which spoke to a connection between the faulty genes and men.

 

About the Author

Alyssa Clark is the Editor of Healthcare Global

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma